RightFit
RecruitingNot applicable

Peripheral Venous Pressure (PVP) Trial

Reducing the Length of Stay and Incidence of Rehospitalization in Heart Failure Patients by Measuring Peripheral Venous Pressure; a Randomized Clinical Trial

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years and older
Sex
All sexes
Healthy volunteers
Not accepted
Compensation
Mentioned in the study description

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

Not stated in the study description — ask the study team about visits and procedures.

Compensation
Mentioned in the study description
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study tests whether giving doctors daily readings of pressure in a vein helps shorten hospital stays and reduce return hospital visits. It is for people admitted to Aurora St. Luke’s Medical Center with worsening heart failure, a condition in which the heart does not pump blood well.

The purpose of the study is to determine if there is a reduction in the length of stay and rates of rehospitalization for patients diagnosed with congestive heart failure when physicians are provided daily measurements of peripheral venous pressure versus no daily measurements of peripheral venous pressure.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Have had heart failure for at least 3 months and are admitted to Aurora St. Luke’s Medical Center because it has suddenly gotten worse.
  • Speak English.

Who can't join

  • Do not already have an IV line, have an IV line that cannot measure vein pressure, or have an IV tube smaller than 22 gauge.
  • Have or have had a blood clot in the arm used for pressure readings; have had more than one blood clot in the lungs; or have an inflamed vein with a clot in the arm.
  • Had a heart attack, stroke, or other major heart or blood vessel event within 2 months before admission, or had a device placed to help coordinate heartbeats within 3 months before admission.
  • Are taking part in another heart or blood vessel research study.
  • Have a condition the study doctor thinks may keep you from finishing the study, a heart problem present at birth, or an artificial mechanical valve on the right side of the heart.
  • Plan to have heart surgery or a procedure on the heart’s arteries during this hospital stay, or are expected to receive a heart transplant within 6 months of admission.
  • Are pregnant or breastfeeding.
  • Cannot give informed consent, meaning you cannot agree to join after learning about the study, or have a breathing tube.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: * Patients with minimum 3-month history of Congestive Heart Failure admitted to Aurora St. Luke's Medical Center with acute decompensation * English speaking only Exclusion Criteria: * Patients who do not already have a peripheral IV line inserted * Patients whose IV line cannot be transduced * Patients with current or past vein thrombosis in the arm used to measure the pressure or with history of recurrent (\>1) pulmonary embolism * Patients with active thrombophlebitis in the arm * Patients who have experienced a major cardiovascular event (myocardial infarction, stroke, etc.) ≤2 months prior to the admission date * Patients who have received an implanted cardiac resynchronization device (pacemaker or ICD) ≤3 months prior to admission date * Patients enrolled in other cardiovascular research studies. * Patients with a clinical condition that the investigator believes may not allow the patient to complete the study, at the discretion of the investigator. Examples of conditions that may apply include severe stenotic valvular disease, isolated right ventricle failure, precapillary pulmonary hypertension, hypertrophic obstructive cardiomyopathy, implanted left ventricular assist device, history of heart transplantation, clinical diagnosis of cardiogenic shock, any left-to-right shunt * Patients with congenital heart disease or mechanical right heart valve(s) * Planned heart surgery and/or coronary intervention during hospitalization * Patients expected to receive heart transplant within 6 months of admission * IV cannula smaller than 22G * Patients who are pregnant and/or lactating * Patients who are unable to provide informed consent * Patients who are intubated

Study sites (1)

WI